These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8296111)

  • 1. Sample sizes for event rate equivalence trials using prior information.
    Gould AL
    Stat Med; 1993 Nov; 12(21):2009-23. PubMed ID: 8296111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inference of equivalence for the ratio of two normal means with unspecified variances.
    Xu S; Hua SY; Menton R; Barker K; Menon S; D'Agostino RB
    J Biopharm Stat; 2014; 24(6):1264-79. PubMed ID: 25033269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherent difficulties with active control equivalence studies.
    Senn S
    Stat Med; 1993 Dec; 12(24):2367-75. PubMed ID: 8134739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning and monitoring of equivalence studies.
    Durrleman S; Simon R
    Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical Bayes models of Poisson clinical trials and sample size determination.
    Zaslavsky BG
    Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian equivalency test for two independent binomial proportions.
    Kawasaki Y; Shimokawa A; Yamada H; Miyaoka E
    J Biopharm Stat; 2016; 26(4):781-9. PubMed ID: 26322683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific statistical considerations relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence.
    Kingman A
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):378-89; discussion 390-4. PubMed ID: 1507027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculations for risk equivalence testing in pharmacoepidemiology.
    Tubert-Bitter P; Manfredi R; Lellouch J; Bégaud B
    J Clin Epidemiol; 2000 Dec; 53(12):1268-74. PubMed ID: 11146274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on statistical methods for assessing therapeutic equivalence.
    Chow SC; Shao J
    Control Clin Trials; 2002 Oct; 23(5):515-20. PubMed ID: 12392865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified Wald test for reference scaled assessment of analytical equivalence.
    Weng YT; Tsong Y; Shen M; Wang C
    J Biopharm Stat; 2019; 29(6):1068-1081. PubMed ID: 30829123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitors in non-ischaemic heart failure: results from the MEGA trials.
    Cohn JN
    Eur Heart J; 1995 Dec; 16 Suppl O():133-6. PubMed ID: 8682080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active control equivalence trials: some methodological aspects.
    Ferner U; Neumann N
    Psychopharmacology (Berl); 1992; 106 Suppl():S93-5. PubMed ID: 1546152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.
    Keyhan G; Chen SF; Pilote L
    Eur J Heart Fail; 2007; 9(6-7):594-601. PubMed ID: 17462947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar, the same or just not different: a guide for deciding whether treatments are clinically equivalent. [Dept. of Medicine, Division of Cardiology, Univ. of Western Ontario, London, Ontario].
    Massel D
    Can J Cardiol; 1999 May; 15(5):556-62. PubMed ID: 10350665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ACE inhibitors in cardiac failure: from research to routine practice. (lecture)].
    Belenkov IuN; Ageev FT; Mareev VIu; Konstantinova EV; Pozharskaia NA; Danielian MO
    Ter Arkh; 2000; 72(4):69-71. PubMed ID: 10833805
    [No Abstract]   [Full Text] [Related]  

  • 19. A Bayesian approach on sample size calculation for comparing means.
    Wang H; Chow SC; Chen M
    J Biopharm Stat; 2005; 15(5):799-807. PubMed ID: 16078386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confidence intervals and sample sizes.
    Grieve AP
    Biometrics; 1991 Dec; 47(4):1597-602; discussion 1602-3. PubMed ID: 1786333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.